Ref ID: 18764
Author:
Y. Yamagishi, MD, PhD – Associate Professor1, N. Kawasumi, PhD – Researcher 1, M. Hagihara, PhD – Researcher 1, T. Sugita, MD, PhD – Associate Professor 2, H. Mikamo, MD, PhD – Professor 1;
Author address:
1Aichi Med. Univ., Aichi, Japan, 2Meiji Pharmaceutical Univ., Tokyo, Japan.
Full conference title:
52nd Annual ICAAC
Date: 9 September 2014
Abstract:
Background: Trichosporon species are the environmental fungi found in soil and is important as the pathogens in opportunistic infections. Those are also important as one of the causes for breakthrough infections due to inappropriate use of antifungal agents. We investigated the correlation between the consumption and the frequency of Trichosporon isolation. Methods: We retrospectively investigated the patients’ background in 62 patients in whom Trichosporon was isolated during the period from 2003 through 2009 at Aichi Medical University Hospital. Statistic analysis was performed with Spearman’s rank correlation coefficient test. We judged significant difference when Spearman’s rank correlation coefficients were > 0.786(p<0.05) Results: Trichosporon species were the most frequently isolated from urine, followed by sputum and stool. Random amplified polymorphic DNA analysis using 8 primers showed possible nosocomial infections. The isolation number of Trichosporon species was associated with the total amount of micafungin (MCFG) usage and the ratio of MCFG usage with 0.811(p=0.03) and 0.613 (p=0.14)of the rank correlation coefficients, respectively. The isolation of Trichosporon species were correlated significantly with the absolute amount (p<0.05)rather than the relative amount of MCFG. Conclusions: Since inappropriate use of antifungal agents would be led to the breakthrough fungal infections,we should also consider the heterogeneitic use of amtifungal agents in each hospital.
Abstract Number: M-328
Conference Poster: y
Conference Year: 2012
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a